Quartz Partners »

Supernus Pharmaceuticals shares owned by Quartz Partners

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Quartz Partners from 13F filings

Historical chart of Quartz Partners investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Quartz Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Quartz Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $863k 28k 31.18

More positions owned by Quartz Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
InterDigital (IDCC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfli High Yld (SPHY)
Ameriprise Financial (AMP)
Leidos Holdings (LDOS)
Bellring Brands Common Stock (BRBR)

View all positions for Quartz Partners

Top funds holding Supernus Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
Armistice Capital
Dimensional Fund Advisors
Macquarie Group
State Street Corporation
Stephens Investment Management Group
Pacer Advisors
Renaissance Technologies
Geode Capital Management
Jennifer Ranahan
Aristotle Capital Boston
American Century Companies
Victory Capital Management

View all funds holding Supernus Pharmaceuticals